PUBLIC PROCUREMENT NOTICEExternal opportunity
Translated into EnglishAI translation · verify material terms against the original
AI-translated presentation
Spain – Various medicinal products – Successive supply of the monoclonal antibody against respiratory syncytial virus, NIRSEVIMAB (Beyfortus®)
Successive supply of the monoclonal antibody against respiratory syncytial virus, NIRSEVIMAB (Beyfortus®) Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Opportunity description
Successive supply of the monoclonal antibody against respiratory syncytial virus, NIRSEVIMAB (Beyfortus®) Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Buyer Sign in to view
Response deadline Sign in to view
Delivery Sign in to view
Estimated value Sign in to view
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.